TNFSF13B and B-cell chronic lymphocytic leukemia: Multivariate regression analyses demonstrated that higher BAFF serum levels were associated with a significant reduction in CLL risk (Ptrend = 5 × 10−6, Fig. 1a), which appeared linear (Supplementary Fig. 1).